AI designs functional enzyme components to aid drug discovery

Researchers report that generative AI can design working enzyme components — protein building blocks usable for producing and improving active pharmaceutical ingredients. The approach sidesteps the complexity of natural biological processes in microorganisms.

• AI designs functional enzyme components, not just static structures
• Target applications include drugs for infections and cancer
• Method bypasses complexity of natural microbial biosynthesis